Purple Biotech Ltd. (PPBT)

Nasdaq: PPBT · Pharmaceutical Preparations · Rehovot, IL · filing with the SEC since 2014

Grade4.7

◀ Past 6.1● Present 3.9▶ Future 4.4

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 19, 2026	Mar 10, 2025	Mar 5, 2024	Mar 3, 2023	Mar 9, 2022	Mar 16, 2021	Mar 23, 2020	Mar 26, 2019	Mar 5, 2018	May 1, 2017
Revenue	·	·	·	·	·	1,000	1,000	1,000	100	·
Research and development	3,731	7,620	17,034	16,320	11,827	7,238^r	2,278^r	5,268	4,640	4,180
Selling, general and administrative	3,245	3,183	5,237	6,283	6,107	6,001^r	4,393^r	5,195	6,397^r	3,003
General and administrative	·	·	·	1,644	1,525	1,889	1,035	227^r	1,570^r	3,003
Total operating expenses	27,458	11,005	22,271	22,603	17,934	13,239^r	6,671^r	8,826	12,066	7,183
Operating income	·	·	-22,271	-22,603	-17,934	-12,612	-7,156	-7,826	-11,966^r	-7,183
Finance costs	982	483	2,195^r	67	-212^r	61	181	576	26	61
Finance income	424	868	992^r	910	-320^r	254	151	93	128	138
Net finance income (costs)	966	3,726	2,294^r	843^r	-108^r	-254	·	·	·	·
Income tax expense	·	·	·	·	·	·	216	·	·	·
Income from continuing operations	26,492	7,279	19,977	21,760	17,826^r	28,701^r	-5,408^r	-5,569	-12,913^r	-12,125
Income from discontinued operations	·	·	·	·	642^r	-627^r	-485	·	·	·
Net income	-26,492	-7,279	-19,977^r	-21,760^r	18,468	28,074	5,893	5,569	12,913^r	12,125
Net income to non-controlling interests	-106	-39	-97^r	-92^r	84	75	43	369	736	·
Net income to shareholders	-26,386	-7,240	-19,880^r	-21,668^r	18,384	27,999	5,850	5,200	12,177^r	12,125
Earnings per share, basic	0.027	4.44	17.96^r	23.97^r	17,568,036.00	·	·	·	·	·
Earnings per share, diluted	0.027	4.99	17.96^r	23.97^r	17,568,036.00	·	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	2.44	-3.00^r	-3.90^r	1.37^r	2.11^r
Weighted average shares, basic	960,106,739	1,639,566	1,106,665	904,054	17,568,036	11,500,113	19,367,484	14,205,301	9,456,952^r	5,755,747^r
Weighted average shares, diluted	480,053	1,639,787	1,106,665	904,054	·	·	·	·	·	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherifrs-full:OperatingExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton PPBT · research, not advice